Patents by Inventor Melissa Virginia REWOLINSKI

Melissa Virginia REWOLINSKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8697730
    Abstract: Described herein are methods for the synthesis of 3-[5-(pyridin-2-ylmethoxy)-3-(2-methyl-2-propylthio)-1-[4-(2-methoxypyridin-5-yl)benzyl]-indol-2-yl]-2,2-dimethyl-propionic acid, pharmaceutically acceptable salts, pharmaceutically acceptable solvates thereof. Also described are pharmaceutical compositions suitable for oral administration to a mammal that include, as well as methods of using such oral pharmaceutical compositions for treating respiratory conditions or diseases, as well as other leukotriene-dependent or leukotriene mediated conditions or diseases.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: April 15, 2014
    Assignee: Panmira Pharmaceuticals, LLC
    Inventors: Melissa Virginia Rewolinski, Kevin Murray Schaab, Christopher David King, Nicholas Simon Stock
  • Publication number: 20100075934
    Abstract: Described herein are methods for the synthesis of 3-[5-(pyridin-2-ylmethoxy)-3-(2-methyl-2-propylthio)-1-[4-(2-methoxypyridin-5-yl)benzyl]-indol-2-yl]-2,2-dimethyl-propionic acid, pharmaceutically acceptable salts, pharmaceutically acceptable solvates thereof. Also described are pharmaceutical compositions suitable for oral administration to a mammal that include, as well as methods of using such oral pharmaceutical compositions for treating respiratory conditions or diseases, as well as other leukotriene-dependent or leukotriene mediated conditions or diseases.
    Type: Application
    Filed: October 24, 2008
    Publication date: March 25, 2010
    Applicant: Amira Pharmaceuticals, Inc.
    Inventors: Melissa Virginia REWOLINSKI, Kevin Murray SCHAAB, Christopher David KING, Jillian F. EVANS, Petpiboon Peppi PRASIT, John Howard HUTCHINSON, Nicholas Simon STOCK